Morgan Stanley’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-62,223
| Closed | -$1.12M | – | 6857 |
|
|
2017
Q4 | $1.12M | Sell |
62,223
-95,109
| -60% | -$1.71M | ﹤0.01% | 4463 |
|
|
2017
Q3 | $1.86M | Buy |
157,332
+7,369
| +5% | +$86.9K | ﹤0.01% | 3958 |
|
|
2017
Q2 | $1.58M | Buy |
149,963
+44,840
| +43% | +$471K | ﹤0.01% | 4003 |
|
|
2017
Q1 | $1.16M | Sell |
105,123
-278,818
| -73% | -$3.07M | ﹤0.01% | 4275 |
|
|
2016
Q4 | $5.2M | Buy |
383,941
+266,302
| +226% | +$3.61M | ﹤0.01% | 2945 |
|
|
2016
Q3 | $1.45M | Sell |
117,639
-198,560
| -63% | -$2.44M | ﹤0.01% | 3753 |
|
|
2016
Q2 | $3.47M | Buy |
316,199
+61,705
| +24% | +$677K | ﹤0.01% | 2937 |
|
|
2016
Q1 | $2.78M | Buy |
254,494
+205,115
| +415% | +$2.24M | ﹤0.01% | 3070 |
|
|
2015
Q4 | $854K | Sell |
49,379
-457,955
| -90% | -$7.92M | ﹤0.01% | 4179 |
|
|
2015
Q3 | $10.1M | Buy |
507,334
+262,128
| +107% | +$5.21M | ﹤0.01% | 1942 |
|
|
2015
Q2 | $4.03M | Sell |
245,206
-130,206
| -35% | -$2.14M | ﹤0.01% | 2991 |
|
|
2015
Q1 | $5.84M | Buy |
375,412
+240,690
| +179% | +$3.75M | ﹤0.01% | 2617 |
|
|
2014
Q4 | $1.93M | Buy |
134,722
+127,522
| +1,771% | +$1.82M | ﹤0.01% | 3597 |
|
|
2014
Q3 | $47K | Sell |
7,200
-12,520
| -63% | -$81.7K | ﹤0.01% | 5751 |
|
|
2014
Q2 | $137K | Sell |
19,720
-31,883
| -62% | -$222K | ﹤0.01% | 5346 |
|
|
2014
Q1 | $369K | Buy |
51,603
+40,292
| +356% | +$288K | ﹤0.01% | 4762 |
|
|
2013
Q4 | $106K | Sell |
11,311
-24,764
| -69% | -$232K | ﹤0.01% | 5331 |
|
|
2013
Q3 | $225K | Buy |
36,075
+14,475
| +67% | +$90.3K | ﹤0.01% | 4810 |
|
|
2013
Q2 | $142K | Buy |
+21,600
| New | +$142K | ﹤0.01% | 4983 |
|